Ligand Pharmaceuticals LGND
NASDAQ LGND
$312.37 +2.01 (+0.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Revenue (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) posted Revenue of $63.69 million for Q2 2026, up 33.7% from $47.63 million a year earlier and up 23.1% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Ligand Pharmaceuticals was $290.54 million, up 54.9% year-over-year; for FY2025, it was $268.09 million, up 60.4% from FY2024.

  • Annual Revenue shows a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
  • In prior years, Ligand Pharmaceuticals' Revenue was $167.13 million in FY2024 (+27.3%), $131.31 million in FY2023 (-33.1%), $196.25 million in FY2022 (-18.8%) and $241.54 million in FY2021 (+47.7%).
  • Quarterly Revenue has run from a low of $26.37 million in Q2 2023 to a high of $115.46 million in Q3 2025 over five years.
  • On a year-over-year basis, Revenue has increased in each of the last nine quarters, with growth averaging 47.6% over the last eight quarters.
  • The strongest year-over-year quarter for Revenue in the past five years was Q3 2025, with growth of 122.8%; the weakest was Q2 2023, with a decline of 47.4%.
  • According to Business Quant data, Revenue for the three prior quarters was $51.72 million (Q1 2026), $59.67 million (Q4 2025) and $115.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 63.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.69 Mn
Mar 31, 2026 51.72 Mn
Dec 31, 2025 59.67 Mn
Sep 30, 2025 115.46 Mn
Jun 30, 2025 47.63 Mn
Mar 31, 2025 45.33 Mn
Dec 31, 2024 42.81 Mn
Sep 30, 2024 51.81 Mn
Jun 30, 2024 41.53 Mn
Mar 31, 2024 30.98 Mn
Dec 31, 2023 28.10 Mn
Sep 30, 2023 32.87 Mn
Jun 30, 2023 26.37 Mn
Mar 31, 2023 43.98 Mn
Dec 31, 2022 50.38 Mn
Sep 30, 2022 59.22 Mn
Jun 30, 2022 50.13 Mn
Mar 31, 2022 36.52 Mn
Dec 31, 2021 56.40 Mn
Sep 30, 2021 59.69 Mn
API Access

Ligand Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=LGND&period=max&api_key=YOUR_API_KEY